Literature DB >> 26184027

Primary hepatic neuroendocrine carcinoma with a cholangiocellular carcinoma component in one nodule.

Yoshihito Kano1, Sei Kakinuma, Fumio Goto, Seishin Azuma, Yuki Nishimura-Sakurai, Yasuhiro Itsui, Mina Nakagawa, Atsushi Kudo, Minoru Tanabe, Susumu Kirimura, Tomonori Amano, Takashi Ito, Takumi Akashi, Yasuhiro Asahina, Mamoru Watanabe.   

Abstract

Primary neuroendocrine carcinomas (NECs) in the liver are very rare; however, several reports have described cases of a primary hepatic NEC combined with a hepatocellular carcinoma (HCC). We present the first report of a primary hepatic NEC with a cholangiocellular carcinoma (CCC) component in one nodule in a patient with a metachronous liver HCC. A 73-year old man who had received partial hepatectomy surgery because of a primary HCC and a primary CCC two years prior was diagnosed with a primary hepatic NEC after surgical treatment. Histological analysis of the resected tumor revealed that the tumor consisted of a predominant NEC area with a partial CCC component in one nodule and that the NEC cells were negative for markers of pancreatic NEC. Neoplastic cells in both the NEC and CCC component focally expressed CD44, a representative marker for cancer-initiating cells, and the CD44-positive cells in the NEC component were seen in the vicinity of those in the CCC component of one nodule. This case report provides suggestive information for the origin of primary hepatic NECs.

Entities:  

Mesh:

Year:  2014        PMID: 26184027     DOI: 10.1007/s12328-014-0521-3

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  19 in total

Review 1.  Biochemical testing for neuroendocrine tumors.

Authors:  Aaron I Vinik; Maria P Silva; Eugene A Woltering; Gene Woltering; Vay Liang W Go; Richard Warner; Martyn Caplin
Journal:  Pancreas       Date:  2009-11       Impact factor: 3.327

2.  Neuroendocrine differentiation in embryonal type hepatoblastoma.

Authors:  Georgios P Fragulidis; Konstantinos Chondrogiannis; Antonios Vezakis; Aikaterini Melemeni; Agatha Kondi-Pafiti; Elias Primetis; Andreas Polydorou; Dionysios C Voros
Journal:  Hepatol Res       Date:  2013-03       Impact factor: 4.288

3.  Primary neuroendocrine tumor in the liver treated by hepatectomy: report of a case.

Authors:  Kosuke Mima; Toru Beppu; Asuka Murata; Ryu Otao; Keisuke Miyake; Hirohisa Okabe; Toshiro Masuda; Kazutoshi Okabe; Shinichi Sugiyama; Akira Chikamoto; Takatoshi Ishiko; Hiroshi Takamori; Hideo Baba
Journal:  Surg Today       Date:  2011-10-04       Impact factor: 2.549

4.  Hepatocellular carcinoma with an unusual neuroendocrine component.

Authors:  Rin Yamaguchi; Osamu Nakashima; Toshiro Ogata; Keiichiro Hanada; Tsutomu Kumabe; Masamichi Kojiro
Journal:  Pathol Int       Date:  2004-11       Impact factor: 2.534

5.  A phase II trial of irinotecan and cisplatin in patients with metastatic neuroendocrine tumors.

Authors:  Matthew H Kulke; Bingyan Wu; David P Ryan; Peter C Enzinger; Andrew X Zhu; Jeffrey W Clark; Craig C Earle; Ann Michelini; Charles S Fuchs
Journal:  Dig Dis Sci       Date:  2006-06       Impact factor: 3.199

6.  Hyaluronan-CD44 Interactions in Cancer: Paradoxes and Possibilities.

Authors:  Bryan P Toole
Journal:  Clin Cancer Res       Date:  2009-12-15       Impact factor: 12.531

7.  The acquisition of malignant potential in colon cancer is regulated by the stabilization of Atonal homolog 1 protein.

Authors:  Yoshihito Kano; Kiichiro Tsuchiya; Xiu Zheng; Nobukatsu Horita; Keita Fukushima; Shuji Hibiya; Yuhki Yamauchi; Tatsunori Nishimura; Kunihiko Hinohara; Noriko Gotoh; Shinji Suzuki; Ryuichi Okamoto; Tetsuya Nakamura; Mamoru Watanabe
Journal:  Biochem Biophys Res Commun       Date:  2013-01-16       Impact factor: 3.575

8.  Combined primary neuroendocrine carcinoma and hepatocellular carcinoma of the liver.

Authors:  Chii-Shuenn Yang; Mei-Chin Wen; Yee-Jee Jan; John Wang; Cheng-Chung Wu
Journal:  J Chin Med Assoc       Date:  2009-08       Impact factor: 2.743

Review 9.  MUC1, the renaissance molecule.

Authors:  S J Gendler
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-07       Impact factor: 2.698

10.  Mixed Adenoneuroendocrine Carcinomas (MANECs) of the Gastrointestinal Tract: An Update.

Authors:  Stefano La Rosa; Alessandro Marando; Fausto Sessa; Carlo Capella
Journal:  Cancers (Basel)       Date:  2012-01-16       Impact factor: 6.639

View more
  5 in total

Review 1.  Mixed Neuroendocrine-Nonneuroendocrine Neoplasms (MiNENs): Unifying the Concept of a Heterogeneous Group of Neoplasms.

Authors:  Stefano La Rosa; Fausto Sessa; Silvia Uccella
Journal:  Endocr Pathol       Date:  2016-12       Impact factor: 3.943

Review 2.  Histological features of mixed neuroendocrine carcinoma and hepatocellular carcinoma in the liver: a case report and literature review.

Authors:  Hiroto Nishino; Etsuro Hatano; Satoru Seo; Shinsuke Shibuya; Takayuki Anazawa; Taku Iida; Toshihiko Masui; Kojiro Taura; Hironori Haga; Shinji Uemoto
Journal:  Clin J Gastroenterol       Date:  2016-07-06

3.  Combination therapies for primary hepatic neuroendocrine carcinoma: a case report.

Authors:  Richi Nakatake; Morihiko Ishizaki; Kosuke Matui; Hiroaki Yanagimoto; Kentaro Inoue; Masaki Kaibori; Yusai Kawaguchi; Masanori Kon
Journal:  Surg Case Rep       Date:  2017-09-11

4.  Long term recurrence in primary liver neuroendocrine tumor: Report of a single case and review of literature.

Authors:  Giovanni Pirozzolo; Camilla Cona; Maurizio Rizzo; Fazli Shala; Sadri Berisha; Alfonso Recordare
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2018-05-30

Review 5.  Primary hepatic neuroendocrine carcinoma coexisting with distal cholangiocarcinoma: A case report and review of the literature.

Authors:  Qi Xin; Rong Lv; Cheng Lou; Zhe Ma; Gui-Qiu Liu; Qin Zhang; Hai-Bo Yu; Chuan-Shan Zhang
Journal:  Medicine (Baltimore)       Date:  2020-06-26       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.